Deepika Garg, MD, FACOG
Assistant Professor of Obstetrics, Gynecology and Reproductive SciencesCards
About
Research
Publications
2022
Effect of chemotherapy on the uterus of young adult cancer survivors
Garg D, Hodgman M, Reil S, Lomo L, Aston K, Hill J, Johnstone E, Jenkins T, Letourneau J. Effect of chemotherapy on the uterus of young adult cancer survivors. F&S Reports 2022, 3: 198-203. PMID: 36212573, PMCID: PMC9532891, DOI: 10.1016/j.xfre.2022.05.008.Peer-Reviewed Original ResearchEndometrial thicknessChemotherapy exposureEndometrial biopsyUterine volumeCancer survivorsHodgkin's lymphomaMenstrual cycleDeoxyribonucleic acid (DNA) methylation patternsCross-sectional pilot studyYoung adult cancer survivorsImpact of chemotherapyRibonucleic acid expression levelsEffect of chemotherapyAdult cancer survivorsGeneral population controlsLate proliferative phaseMedian uterine volumeUniversity fertility clinicPelvic radiationEndometrial histologyPelvic ultrasoundCervical cancerFalse-positive resultsMenstruating womenStudy visit
2021
EFFECT OF ALKYLATING AGENT CHEMOTHERAPY ON THE UTERUS OF YOUNG ADULT CANCER SURVIVORS
Garg D, Jenkins T, Johnstone E, Aston K, Letourneau J. EFFECT OF ALKYLATING AGENT CHEMOTHERAPY ON THE UTERUS OF YOUNG ADULT CANCER SURVIVORS. Fertility And Sterility 2021, 116: e474. DOI: 10.1016/j.fertnstert.2021.08.028.Peer-Reviewed Original ResearchCancer treatment is associated with a measurable decrease in live births in a large, population-based study
Garg D, Meeks H, Johnstone E, Berga S, Smith K, Hotaling J, Letourneau J. Cancer treatment is associated with a measurable decrease in live births in a large, population-based study. F&S Reports 2021, 2: 462-467. PMID: 34934988, PMCID: PMC8655402, DOI: 10.1016/j.xfre.2021.08.004.Peer-Reviewed Original ResearchIncidence rate ratiosPopulation-based studyLive birth rateAge-matched controlsLive birthsCancer survivorsCancer typesHealthy controlsBreast cancerLower live birth ratesCancer treatmentCentral nervous system cancerRetrospective cohort studyFemale cancer patientsNon-cancer controlsNervous system cancersAge 18 yearsCommon cancer typesSoft tissue cancerBirth rateCohort studyGastrointestinal cancerCancer patientsSystem cancersMAIN OUTCOME
2020
LIKELIHOOD OF WOMEN ACHIEVING MORE THAN ONE LIVE BIRTH AFTER VARIOUS TYPES OF CANCERS
Garg D, Meeks H, Johnstone E, Berga S, Smith K, Hotaling J, Letourneau J. LIKELIHOOD OF WOMEN ACHIEVING MORE THAN ONE LIVE BIRTH AFTER VARIOUS TYPES OF CANCERS. Fertility And Sterility 2020, 114: e253. DOI: 10.1016/j.fertnstert.2020.10.012.Peer-Reviewed Original ResearchLooking beyond the ovary for oncofertility care in women: uterine injury as a potential target for fertility-preserving treatments
Garg D, Johnstone E, Lomo L, Fair D, Rosen M, Taylor R, Silver B, Letourneau J. Looking beyond the ovary for oncofertility care in women: uterine injury as a potential target for fertility-preserving treatments. Journal Of Assisted Reproduction And Genetics 2020, 37: 1467-1476. PMID: 32342270, PMCID: PMC7311602, DOI: 10.1007/s10815-020-01792-9.Peer-Reviewed Original ResearchConceptsCancer survivorsPregnancy complicationsObstetrical outcomesFertility-preserving treatmentLow birth weightPoor obstetrical outcomesFemale cancer survivorsImpact of chemotherapyEarly pregnancy lossOncofertility carePregnancy implantationLate complicationsPregnancy outcomesPreterm birthRadiation fibrosisEndometrial receptivityGonadotoxic effectsUterine injuryBirth weightPregnancy lossPregnant uterusBlood supplyUterine functionChemotherapyComplicationsMP26-10 PATERNAL CANCER HISTORY DOES NOT INCREASE OBSTETRIC COMPLICATIONS
Gross* K, Meeks H, Garg D, Patel D, Pastuszak A, Hanson H, Smith K, Letourneau J, Hotaling J. MP26-10 PATERNAL CANCER HISTORY DOES NOT INCREASE OBSTETRIC COMPLICATIONS. Journal Of Urology 2020, 203 DOI: 10.1097/ju.0000000000000865.010.Peer-Reviewed Original ResearchMP26-09 MEN WITH CANCER DIAGNOSIS ARE OLDER AT TIME OF FIRST LIVE BIRTH:AN AGE-MATCHED COHORT ANALYSIS OF THE UTAH POPULATION DATABASE
Patel* D, Meeks H, Garg D, Gross K, Pastuszak A, Hanson H, Smith K, Letourneau J, Hotaling J. MP26-09 MEN WITH CANCER DIAGNOSIS ARE OLDER AT TIME OF FIRST LIVE BIRTH:AN AGE-MATCHED COHORT ANALYSIS OF THE UTAH POPULATION DATABASE. Journal Of Urology 2020, 203 DOI: 10.1097/ju.0000000000000865.09.Peer-Reviewed Original ResearchPD25-06 MEN WITH PREVIOUS CANCER DIAGNOSIS HAVE LOWER PARITY: A CASE-CONTROL ANALYSIS OF THE UTAH POPULATION DATABASE
Gross* K, Meeks H, Garg D, Patel D, Pastuszak A, Hanson H, Smith K, Letourneau J, Hotaling J. PD25-06 MEN WITH PREVIOUS CANCER DIAGNOSIS HAVE LOWER PARITY: A CASE-CONTROL ANALYSIS OF THE UTAH POPULATION DATABASE. Journal Of Urology 2020, 203 DOI: 10.1097/ju.0000000000000882.06.Peer-Reviewed Original ResearchTHE POTENTIAL IMPACT OF CANCER TREATMENT ON LIVE BIRTHS IN MEN AND WOMEN IN A LARGE POPULATION-BASED STUDY
Garg D, Meeks H, Johnstone E, Pastuszak A, Berga S, Smith K, Hotaling J, Letourneau J. THE POTENTIAL IMPACT OF CANCER TREATMENT ON LIVE BIRTHS IN MEN AND WOMEN IN A LARGE POPULATION-BASED STUDY. Fertility And Sterility 2020, 113: e4. DOI: 10.1016/j.fertnstert.2020.02.009.Peer-Reviewed Original ResearchChapter 1 Neuroendocrine mechanisms of reproduction
Garg D, Berga SL. Chapter 1 Neuroendocrine mechanisms of reproduction. Handbook Of Clinical Neurology 2020, 171: 3-23. PMID: 32736757, DOI: 10.1016/b978-0-444-64239-4.00001-1.Peer-Reviewed Original ResearchConceptsGnRH driveNeuroendocrinology of reproductionReproductive functionFunctional hypothalamic amenorrheaSex steroid hormone synthesisFollicle-stimulating hormoneGonadotropin-releasing hormoneStress-induced anovulationSteroid hormone synthesisAbsence of oocytesHypothalamic amenorrheaHypothalamic hypogonadismCongenital causesCeliac diseaseMenstrual cyclePsychogenic amenorrheaCommon causeGonadal axisEndocrine effectsAnterior pituitaryBrain tumorsBehavioral variablesSecondary insufficiencyAppropriate secretionNeuroendocrine mechanisms
Academic Achievements & Community Involvement
Clinical Care
Overview
Deepika Garg, MD, is an obstetrician-gynecologist who specializes in reproductive endocrinology. She focuses on infertility, fertility preservation, recurrent pregnancy loss, and minimally invasive gynecologic surgery.
Dr. Garg says she was drawn to reproductive endocrinology and infertility (REI) during her Ob/Gyn residency training.
“When I was delivering babies for patients, I would have the chance to hear their stories of how they became pregnant,” she says. “For many of them, it was after fertility treatment and challenging times. They would be very emotional about finally having their baby. I realized I wanted to help women with those fertility challenges.”
One of the highlights of her job, Dr. Garg says, is the diversity of care she can provide to a wide range of patients. “I love that I have the combination of surgical and medical specialties rolled into one,” she says. “Coming from India, I am sensitive to different cultures and backgrounds and understand the importance starting a family can have for many people.”
When she meets a patient for the first time, Dr. Garg says the most important thing she can do is listen. “I ask them what they want to know from me rather than immediately jumping into a long medical explanation,” she says.
Dr. Garg’s research interests include fertility preservation.
Clinical Specialties
Fact Sheets
In Vitro Fertilization (IVF)
Learn More on Yale MedicineSurrogacy
Learn More on Yale Medicine
Yale Medicine News
Links
Get In Touch
Contacts
Locations
Patient Care Locations
Are You a Patient? View this doctor's clinical profile on the Yale Medicine website for information about the services we offer and making an appointment.